Step 1 of 2
For decades, 3-drug regimens (3DRs) were considered the “gold standard” of antiretroviral therapy for HIV. However, numerous clinical trials and real-world studies demonstrated that modern 2-drug regimens (2DRs), both oral and long-acting injectable, are noninferior to 3DR alternatives. Download these slides to see practical frameworks and evidence to help you make confident, individualized decisions between 2- and 3-drug regimens when initiating antiretroviral therapy.